Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / ADH5

ADH5

Basics

Aliases:
This biomarker is also known as:
  • formaldehyde dehydrogenase,
  • GSH-FDH,
  • Alcohol dehydrogenase class chi chain,
  • alcohol dehydrogenase (class III), chi polypeptide,
  • alcohol dehydrogenase class-3,
  • Alcohol dehydrogenase 5,
  • GSNOR,
  • alcohol dehydrogenase class-III,
  • EC 1.1.1.1,EC 1.1.1.-,EC 1.1.1.284,
  • alcohol dehydrogenase class chi chain,
  • ADHX,
  • alcohol dehydrogenase 5 (class III), chi polypeptide,
  • FDH,
  • glutathione-dependent formaldehyde dehydrogenase,
  • ADH-3,
  • FALDH,
  • S-(hydroxymethyl)glutathione dehydrogenase,
  • Alcohol dehydrogenase class-III,
  • Glutathione-dependent formaldehyde dehydrogenase,

View in BioMuta

Description…

ADH5 is a member of the alcohol dehydrogenase family. This protein forms a homodimer. ADH5 is ineffective in oxidizing ethanol, but exhibits high activity for oxidation of long-chain primary alcohols and for oxidation of S-hydroxymethyl-glutathione, a spontaneous adduct between formaldehyde and glutathione. There are several non-transcribed pseuodogenes related to this gene.

Attributes

QA State: Curated
Type: Protein
Short Name:
HGNC Name: ADH5

Datasets

There are no datasets associated with this biomarker.

Organs

The following organs have data associated with this biomarker…

Breast

Attributes

Phase: Two
QA State: Under Review

Overview

No additional breast data available.

Performance Comment

ADH5 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

No associated publications found.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.

Announcement